Symbols / IMRN $0.79 -2.88% Immuron Limited

Healthcare • Biotechnology • Australia • NCM
IMRN Chart
About

Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. In additon, the company develops IMM-986, that is in pre-clinical stage. Further, it offers technology platform. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 8.11M
Enterprise Value 251.86M Income -4.65M Sales 7.48M
Book/sh 1.11 Cash/sh 0.03 Dividend Yield —
Payout 0.00% Employees 7 IPO —
P/E — Forward P/E -79.35 PEG —
P/S 1.08 P/B 0.72 P/C —
EV/EBITDA -53.14 EV/Sales 33.68 Quick Ratio 6.75
Current Ratio 8.04 Debt/Eq 1.56 LT Debt/Eq —
EPS (ttm) -0.52 EPS next Y -0.01 EPS Growth —
Revenue Growth 4.80% Earnings 2019-08-29 20:00 ROA -21.93%
ROE -39.68% ROIC — Gross Margin 63.69%
Oper. Margin -47.16% Profit Margin -62.14% Shs Outstand 8.17M
Shs Float 322.66M Short Float 0.56% Short Ratio 1.25
Short Interest — 52W High 2.39 52W Low 0.68
Beta 0.36 Avg Volume 39.15K Volume 221.00
Target Price $3.87 Recom None Prev Close $0.82
Price $0.79 Change -2.88%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.88
Mean price target
2. Current target
$0.79
Latest analyst target
3. DCF / Fair value
$-7.54
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.79
Low
$3.88
High
$3.88
Mean
$3.88

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-09-26 init Litchfield Hills — → Buy $5
2017-10-18 init HC Wainwright & Co. — → Buy $15
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Total Revenue
7.29
+48.63%
4.90
+171.67%
1.80
+135.85%
0.77
Operating Revenue
7.29
+48.63%
4.90
+171.67%
1.80
+135.85%
0.77
Cost Of Revenue
2.52
+61.03%
1.57
+216.02%
0.50
+105.04%
0.24
Reconciled Cost Of Revenue
2.52
+61.03%
1.57
+216.02%
0.50
+105.04%
0.24
Gross Profit
4.77
+42.80%
3.34
+154.88%
1.31
+150.07%
0.52
Operating Expense
10.12
+18.35%
8.55
+81.37%
4.72
+29.52%
3.64
Research And Development
3.60
-33.08%
5.38
+107.38%
2.59
+294.11%
0.66
Selling General And Administration
7.87
+20.09%
6.55
+29.00%
5.08
+30.56%
3.89
Selling And Marketing Expense
3.45
+70.10%
2.03
+118.85%
0.93
+122.65%
0.42
General And Administrative Expense
4.41
-2.36%
4.52
+8.93%
4.15
+19.52%
3.47
Salaries And Wages
2.61
+2.92%
2.54
+13.09%
2.24
+63.73%
1.37
Other Gand A
1.45
-12.80%
1.66
+12.91%
1.47
-13.46%
1.70
Other Operating Expenses
-1.41
+58.59%
-3.41
-12.76%
-3.02
-215.58%
-0.96
Total Expenses
12.64
+24.95%
10.12
+94.17%
5.21
+34.22%
3.88
Operating Income
-5.36
-2.70%
-5.22
-53.11%
-3.41
-9.27%
-3.12
Total Operating Income As Reported
-5.34
+7.87%
-5.80
-62.55%
-3.57
-24.36%
-2.87
EBITDA
-5.16
+25.05%
-6.88
-84.63%
-3.73
-32.89%
-2.81
Normalized EBITDA
-5.17
+17.89%
-6.30
-76.62%
-3.57
-16.80%
-3.05
Reconciled Depreciation
0.05
+8.06%
0.05
-5.51%
0.05
+14.21%
0.04
EBIT
-5.21
+24.83%
-6.93
-83.47%
-3.78
-32.61%
-2.85
Total Unusual Items
0.01
+102.08%
-0.59
-260.58%
-0.16
-165.57%
0.25
Total Unusual Items Excluding Goodwill
0.01
+102.08%
-0.59
-260.58%
-0.16
-165.57%
0.25
Special Income Charges
0.00
0.00
+100.00%
-0.00
0.00
Other Special Charges
—
—
—
—
Write Off
0.00
0.00
-100.00%
0.00
0.00
Net Income
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Pretax Income
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Net Non Operating Interest Income Expense
0.13
-59.85%
0.32
+200.16%
0.11
+583.74%
0.02
Interest Expense Non Operating
0.01
-3.58%
0.01
-21.51%
0.01
+56.08%
0.01
Net Interest Income
0.13
-59.85%
0.32
+200.16%
0.11
+583.74%
0.02
Interest Expense
0.01
-3.58%
0.01
-21.51%
0.01
+56.08%
0.01
Interest Income Non Operating
0.14
-58.55%
0.33
+181.76%
0.12
+433.96%
0.02
Interest Income
0.14
-58.55%
0.33
+181.76%
0.12
+433.96%
0.02
Other Income Expense
0.01
+100.60%
-2.04
-319.45%
-0.49
-296.58%
0.25
Gain On Sale Of Security
0.01
+102.08%
-0.59
-265.93%
-0.16
-164.61%
0.25
Tax Provision
0.00
0.00
0.00
0.00
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Net Income From Continuing Operation Net Minority Interest
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Net Income From Continuing And Discontinued Operation
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Net Income Continuous Operations
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Normalized Income
-5.23
+17.69%
-6.35
-75.26%
-3.62
-16.84%
-3.10
Net Income Common Stockholders
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Diluted EPS
-0.91
+25.33%
-1.22
-83.13%
-0.66
-32.80%
-0.50
Basic EPS
-0.91
+25.33%
-1.22
-83.13%
-0.66
-32.80%
-0.50
Basic Average Shares
5.79
+1.42%
5.70
+0.04%
5.70
+0.23%
5.69
Diluted Average Shares
5.79
+1.42%
5.70
+0.04%
5.70
+0.23%
5.69
Diluted NI Availto Com Stockholders
-5.22
+24.81%
-6.94
-83.20%
-3.79
-32.66%
-2.85
Depreciation Amortization Depletion Income Statement
0.05
+8.06%
0.05
-5.51%
0.05
+14.21%
0.04
Depreciation And Amortization In Income Statement
0.05
+8.06%
0.05
-5.51%
0.05
+14.21%
0.04
Depreciation Income Statement
0.05
+8.06%
0.05
-5.51%
0.05
+14.21%
0.04
Earnings From Equity Interest
0.00
+100.00%
-1.46
-348.92%
-0.32
0.00
Insurance And Claims
0.35
+9.94%
0.32
-26.00%
0.43
+8.37%
0.40
Other Taxes
—
—
—
—
Provision For Doubtful Accounts
0.02
+264.57%
-0.01
-161.15%
0.02
+116.95%
0.01
Rent And Landing Fees
—
0.02
0.00
0.00
Rent Expense Supplemental
—
0.02
0.00
0.00
Line Item Trend 2024-06-30
Total Assets
15.55
Current Assets
14.73
Cash Cash Equivalents And Short Term Investments
11.66
Cash And Cash Equivalents
11.66
Cash Financial
11.66
Other Short Term Investments
0.00
Receivables
1.39
Accounts Receivable
0.59
Gross Accounts Receivable
0.61
Allowance For Doubtful Accounts Receivable
-0.02
Other Receivables
0.80
Inventory
1.58
Raw Materials
0.14
Work In Process
0.68
Finished Goods
0.61
Prepaid Assets
0.09
Other Current Assets
0.01
Total Non Current Assets
0.82
Net PPE
0.15
Gross PPE
0.65
Accumulated Depreciation
-0.50
Properties
0.00
Machinery Furniture Equipment
0.41
Other Properties
—
Leases
0.24
Investments And Advances
0.00
Long Term Equity Investment
0.00
Other Non Current Assets
0.67
Total Liabilities Net Minority Interest
2.84
Current Liabilities
2.70
Payables And Accrued Expenses
2.14
Payables
0.69
Accounts Payable
0.65
Other Payable
0.04
Current Accrued Expenses
1.45
Employee Benefits
0.01
Pensionand Other Post Retirement Benefit Plans Current
0.52
Current Debt And Capital Lease Obligation
0.04
Current Capital Lease Obligation
0.04
Current Deferred Liabilities
0.00
Current Deferred Revenue
0.00
Other Current Liabilities
0.04
Total Non Current Liabilities Net Minority Interest
0.14
Long Term Debt And Capital Lease Obligation
0.13
Long Term Capital Lease Obligation
0.13
Stockholders Equity
12.71
Common Stock Equity
12.71
Capital Stock
88.50
Common Stock
88.50
Share Issued
228.00
Ordinary Shares Number
228.00
Treasury Shares Number
0.00
Retained Earnings
-78.97
Gains Losses Not Affecting Retained Earnings
3.17
Total Equity Gross Minority Interest
12.71
Total Capitalization
12.71
Working Capital
12.03
Invested Capital
12.71
Total Debt
0.13
Capital Lease Obligations
0.13
Net Tangible Assets
12.71
Tangible Book Value
12.71
Current Provisions
—
Other Inventories
0.15
Line Item Trend 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Investing Cash Flow
-2.90
-985.46%
0.33
+112.50%
-2.62
-22433.47%
0.01
Cash Flow From Continuing Investing Activities
-2.90
-985.46%
0.33
+112.50%
-2.62
-22433.47%
0.01
Net PPE Purchase And Sale
0.00
+100.00%
-0.00
+97.48%
-0.01
+22.98%
-0.01
Purchase Of PPE
0.00
+100.00%
-0.00
+97.48%
-0.01
+22.98%
-0.01
Capital Expenditure
—
-0.00
+97.48%
-0.01
+22.98%
-0.01
Net Investment Purchase And Sale
-3.04
0.00
0.00
—
Purchase Of Investment
-3.04
0.00
0.00
—
Net Business Purchase And Sale
0.00
0.00
+100.00%
-2.73
0.00
Purchase Of Business
0.00
0.00
+100.00%
-2.73
0.00
Financing Cash Flow
0.20
+23994.93%
0.00
+101.86%
-0.04
-5.23%
-0.04
Cash Flow From Continuing Financing Activities
0.20
+23994.93%
0.00
+101.86%
-0.04
-5.23%
-0.04
Net Issuance Payments Of Debt
-0.07
-321.04%
-0.02
+55.46%
-0.04
+3.44%
-0.04
Issuance Of Debt
—
—
0.00
0.00
Repayment Of Debt
-0.07
-321.04%
-0.02
+55.46%
-0.04
+3.44%
-0.04
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
-0.07
-321.04%
-0.02
+55.46%
-0.04
+3.44%
-0.04
Net Long Term Debt Issuance
-0.07
-321.04%
-0.02
+55.46%
-0.04
+3.44%
-0.04
Net Common Stock Issuance
0.40
+1553.45%
0.02
0.00
0.00
Cash Dividends Paid
0.00
0.00
0.00
0.00
Net Other Financing Charges
-0.12
—
—
—
Changes In Cash
-8.84
-59.19%
-5.55
-5.52%
-5.26
-65.52%
-3.18
Effect Of Exchange Rate Changes
0.01
-78.04%
0.05
-84.13%
0.31
+28.62%
0.24
Beginning Cash Position
11.66
-32.07%
17.16
-22.39%
22.11
-11.73%
25.05
End Cash Position
2.83
-75.72%
11.66
-32.07%
17.16
-22.39%
22.11
Free Cash Flow
-6.14
-4.36%
-5.88
-125.91%
-2.60
+17.57%
-3.16
Cash Flowsfromusedin Operating Activities Direct
-6.14
-4.37%
-5.88
-126.58%
-2.60
+17.56%
-3.15
Classesof Cash Payments
-14.77
-14.42%
-12.91
-64.63%
-7.84
-69.41%
-4.63
Classesof Cash Receiptsfrom Operating Activities
8.64
+22.83%
7.03
+34.00%
5.25
+254.20%
1.48
Common Stock Issuance
0.40
+1553.45%
0.02
0.00
0.00
Interest Paid CFF
-0.01
+3.58%
-0.01
+21.51%
-0.01
-56.08%
-0.01
Interest Received CFI
0.14
-58.55%
0.33
+181.76%
0.12
+433.96%
0.02
Issuance Of Capital Stock
0.40
+1553.45%
0.02
0.00
0.00
Other Cash Receiptsfrom Operating Activities
—
—
—
—
Paymentsto Suppliersfor Goodsand Services
-14.77
-14.42%
-12.91
-64.63%
-7.84
-69.41%
-4.63
Receiptsfrom Customers
7.59
+60.37%
4.73
+147.52%
1.91
+174.57%
0.70
Receiptsfrom Government Grants
0.27
-85.55%
1.90
-38.31%
3.08
+544.01%
0.48
Taxes Refund Paid Direct
0.77
+94.54%
0.40
+56.76%
0.25
-17.69%
0.31
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category